VOYAGEUR PHARMACEUTICALS LTD (VM.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:VM - CA92918C1014 - Common Stock
VM.CA Key Statistics, Chart & Performance
The current stock price of VM.CA is 0.17 CAD. In the past month the price increased by 6.25%. In the past year, price increased by 142.86%.
VM.CA Latest News, Press Relases and Analysis
About VM.CA
Company Profile
Voyageur Pharmaceuticals Ltd. engages in exploring and development of barite, iodine, and fullerene Active Pharmaceutical Ingredient (API) minerals. The company is headquartered in Calgary, Alberta. The company went IPO on 2012-05-18. The company focuses on vertically integrating the barium and iodine contrast markets. In addition, Voyageur is pursuing the development of new endo fullerene drugs. Its products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. At the core of its operations, the Company also owns a 100% interest in the Frances Creek Project, which boasts a mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.
Company Info
VOYAGEUR PHARMACEUTICALS LTD
Dome Tower 800, 333 7 Ave. S.W.
Calgary ALBERTA T2G 2B3 CA
CEO: Brent Willis
Employees: 0
Phone: 14039235944
VOYAGEUR PHARMACEUTICALS LTD / VM.CA FAQ
What does VM do?
Voyageur Pharmaceuticals Ltd. engages in exploring and development of barite, iodine, and fullerene Active Pharmaceutical Ingredient (API) minerals. The company is headquartered in Calgary, Alberta. The company went IPO on 2012-05-18. The company focuses on vertically integrating the barium and iodine contrast markets. In addition, Voyageur is pursuing the development of new endo fullerene drugs. Its products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. At the core of its operations, the Company also owns a 100% interest in the Frances Creek Project, which boasts a mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.
Can you provide the latest stock price for VOYAGEUR PHARMACEUTICALS LTD?
The current stock price of VM.CA is 0.17 CAD. The price increased by 9.68% in the last trading session.
Does VM stock pay dividends?
VM.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of VM stock?
VM.CA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
How many employees does VOYAGEUR PHARMACEUTICALS LTD have?
VOYAGEUR PHARMACEUTICALS LTD (VM.CA) currently has 0 employees.
VM.CA Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to VM.CA. When comparing the yearly performance of all stocks, VM.CA is one of the better performing stocks in the market, outperforming 88.62% of all stocks.
VM.CA Financial Highlights
Over the last trailing twelve months VM.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by -46.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -84.97% | ||
| ROE | -216.61% | ||
| Debt/Equity | 0.03 |